Takeda Pharmaceutical Company Limited (TAK)

Takeda Pharmaceutical Ratios and Metrics

Market cap in millions USD. Fiscal year is April - March.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 27, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Market Capitalization	46,801	45,074	43,399	50,869	44,662	56,329
Market Cap Growth	3.86%	3.86%	-14.68%	13.90%	-20.71%	17.61%
Enterprise Value	79,180	78,050	75,918	81,755	74,563	98,218
Last Close Price	14.90	14.87	13.63	15.65	13.11	16.08
PE Ratio	64.94	62.54	45.57	21.33	23.57	16.57
PS Ratio	1.53	1.47	1.54	1.68	1.52	1.95
PB Ratio	1.01	0.97	0.90	1.06	0.95	1.20
P/FCF Ratio	7.91	7.88	12.14	8.08	5.42	6.92
P/OCF Ratio	6.63	6.39	9.16	6.92	4.83	6.16
EV/Sales Ratio	2.59	2.55	2.69	2.70	2.54	3.40
EV/EBITDA Ratio	9.61	9.65	10.09	8.98	7.65	11.04
EV/EBIT Ratio	21.06	26.02	23.28	17.54	15.09	25.62
EV/FCF Ratio	13.37	13.65	21.23	12.99	9.06	12.07
Debt / Equity Ratio	0.73	0.73	0.75	0.77	0.85	0.98
Debt / EBITDA Ratio	4.19	4.19	4.60	3.86	4.07	5.16
Debt / FCF Ratio	5.92	5.92	10.10	5.81	4.81	5.64
Asset Turnover	0.31	0.31	0.29	0.30	0.27	0.25
Inventory Turnover	1.30	1.30	1.30	1.36	1.40	1.34
Quick Ratio	0.44	0.44	0.50	0.49	0.73	1.00
Current Ratio	1.01	1.01	1.11	0.97	1.21	1.53
Return on Equity (ROE)	1.52%	1.52%	2.12%	5.27%	4.24%	7.60%
Return on Assets (ROA)	1.91%	1.91%	2.12%	2.85%	2.88%	2.06%
Return on Capital (ROIC)	2.27%	2.27%	2.57%	3.57%	3.62%	2.59%
Return on Capital Employed (ROCE)	3.80%	3.80%	3.90%	5.40%	5.40%	3.80%
Earnings Yield	1.54%	1.60%	2.20%	4.69%	4.24%	6.04%
FCF Yield	12.65%	12.69%	8.24%	12.37%	18.44%	14.44%
Dividend Yield	1.77%	8.80%	9.12%	8.65%	11.30%	10.12%
Payout Ratio	59.51%	280.28%	199.34%	88.14%	123.30%	75.36%
Buyback Yield / Dilution	-1.58%	-1.58%	-0.67%	0.46%	-0.23%	-0.47%
Total Shareholder Return	0.19%	7.22%	8.45%	9.12%	11.07%	9.65%

Updated Jan 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q